IGM Biosciences (IGMS) Earnings Date, Estimates & Call Transcripts $1.27 -0.08 (-5.93%) Closing price 04:00 PM EasternExtended Trading$1.28 +0.01 (+1.10%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IGM Biosciences Earnings Summary IGM Biosciences posted Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.86, which missed the consensus estimate of -$0.41 by $0.45. Quarterly revenue was reported to be $0.50 million, below analyst estimates of $4.25 million. With a trailing EPS of -$3.27, IGM Biosciences' earnings are expected to grow next year, from ($3.35) to ($0.96) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 13) -$0.41 Actual EPS (May. 13) -$0.86 Missed By -$0.45 Actual Revenue (May. 13) $0.50MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)IGMS Upcoming EarningsIGM Biosciences' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 7, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get IGM Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IGM Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIGMS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IGMS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. IGM Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.85-$0.46-$0.66Q2 20252-$0.88-$0.38-$0.63Q3 20252-$0.90-$0.40-$0.65Q4 20252-$0.93-$0.40-$0.67 IGM Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/13/2025Q1 2025-$0.41-$0.86 -$0.45-$0.86$4.25M$0.50M3/6/2025Q4 2024-$0.74-$0.61+$0.13-$0.61$0.39M$0.41M11/8/2024--$0.82-$1.01 -$0.19-$1.01$0.23M$0.52M8/14/2024-$0.18-$0.79 -$0.97-$0.79$51.75M$1.25M5/8/2024Q1 2024-$0.84-$0.83+$0.01-$0.83$0.71M$0.50M3/7/2024Q4 2023-$1.06-$1.01+$0.05-$1.01$0.95M$0.65M11/13/2023Q3 2023-$1.25-$1.04+$0.21-$1.04$0.73M$0.51M8/3/2023Q2 2023-$1.40-$1.43 -$0.03-$1.43$0.80M$0.45M IGM Biosciences Earnings - Frequently Asked Questions When is IGM Biosciences' earnings date? IGM Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on IGMS's earnings history. Did IGM Biosciences beat their earnings estimates last quarter? In the previous quarter, IGM Biosciences (NASDAQ:IGMS) missed the analysts' consensus estimate of ($0.41) by $0.45 with a reported earnings per share (EPS) of ($0.86). Learn more on analysts' earnings estimate vs. IGMS's actual earnings. How much revenue does IGM Biosciences generate each year? IGM Biosciences (NASDAQ:IGMS) has a recorded annual revenue of $2.68 million. How much profit does IGM Biosciences generate each year? IGM Biosciences (NASDAQ:IGMS) has a recorded net income of -$195.79 million. IGMS has generated -$3.27 earnings per share over the last four quarters. What is IGM Biosciences' EPS forecast for next year? IGM Biosciences' earnings are expected to grow from ($3.35) per share to ($0.96) per share in the next year. More Earnings Resources from MarketBeat Related Companies AVTE Earnings Results AVIR Earnings Results DBVT Earnings Results ANNX Earnings Results OLMA Earnings Results RCKT Earnings Results CMPS Earnings Results AARD Earnings Results ABEO Earnings Results GLUE Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:IGMS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
